Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Search
99 result(s) found, displaying 51 to 75
-
ConsultationConsultation on IVDs for self-testing. Closing date: 6 May 2014
-
Media releasesConsultation on low value turnover exemption (LVT) scheme
-
-
Media releasesThe amendments made to the Therapeutic Goods Act 1989 (the Act) by the Therapeutic Goods Amendment (2013 Measures No. 1) Act 2014 commenced on 28 February 2014.
-
Media releases
-
Media releasesThe TGA reviewed studies on tartrazine, a yellow colouring used in medicines, and found it safe when properly labelled, with no strong evidence of harm like allergies or behavioural issues.
-
Media releases
-
Media releases
-
Media releasesPilot web service for transmission of adverse event reports from medical software to the Therapeutic Goods Administration
-
ConsultationConsultation on proposed amendments to regulatory framework. Closing date: 7 June 2013
-
ConsultationConsultation on draft RIS. Closing date: 3 June 2013
-
-
ConsultationConsultation: Changes to premarket assessment requirements for medical devices: Proposal paper
-
ConsultationANZTPA implementation - Release of high level description of a possible joint regulatory scheme
-
ConsultationConsultation on proposed advisory statements. Closing date: 7 December 2012
-
Safety updatesThe TGA Prescription Medicines Streamlined Submissions Process Newsletter [formerly the Prescription medicine BPR update (BPR update)] reports on progress of the streamlined submission process.
-
ConsultationConsultation on proposed advisory statements. Closing date: 4 June 2012
-
Safety updatesThe Prescription medicine BPR update (BPR update) reports on progress of the streamlined submission process. Each quarter, an update is provided on the PI/CMI project and the AusPAR project.
-
Media releasesThe Australian government will introduce a comprehensive package of reforms for Australia's Therapeutic Goods Administration (TGA) to ensure the regulation of medicines and medical devices is more effective and transparent.
-
Media releasesThe TGA intends to cancel all pain-killers containing dextropropoxyphene - Capadex, Di-Gesic, Doloxene and Paradex - from the Australian Register of Therapeutic Goods (ARTG), from 1 March 2012.
-
Media releasesThe Australian Customs and Border Protection Service and the Therapeutic Goods Administration have taken part in an international ‘Week of Action’ targeting the online sale of counterfeit and illegal medicines.
-
Media releasesContrary to media reports today, the TGA has not approved the use of Nembutal by Dr Nitschke.
-
Media releasesThe Australian Government today released the report of the Therapeutic Goods Administration (TGA) Transparency Review panel, chaired by Professor Dennis Pearce.
-
Media releasesEight synthetic cannabis-like substances will be classified as prohibited substances throughout Australia from 8 July, Parliamentary Secretary for Health and Ageing, Catherine King, has announced.
-
Media releasesLandmark agreement to achieve world standards in therapeutic products
media release, The Hon Julia Gillard MP - Prime Minister of Australia